Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects

American Journal of Hypertension

Volumn 17, Issue 9, 2004, Pages 817-822

  Angeli, Fabio ^a   Verdecchia, Paolo ^a   Reboldi, Gian Paolo ^a   Gattobigio, Roberto ^a   Bentivoglio, Maurizio ^a   Staessen, Jan A ^b   Porcellati, Carlo ^a  

^a Ospedale Silvestrini   (Italy)

^b Laboratory of Hypertension   (Belgium)

Author keywords

calcium channel blockers; hypertension; prevention; Stroke; therapy

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; FOSINOPRIL; ISRADIPINE; LACIDIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; SB 201823 A; TRANDOLAPRIL; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 4444352548     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(04)00863-5     Document Type: Article

References (36)

1. S.J. Phillips, J.P. Whisnant Hypertension and stroke J.H. Laragh B.M. Brenner Hypertension Pathophysiology, Diagnosis and Management 2nd ed 1995 Raven Press New York 465 478
2. L.L. Bronner, D.S. Kanter, J.E. Manson Primary prevention of stroke N Engl J Med 23 1995 1392 1400
3. O.H. Klungel, B.H.C. Stricker, A.H.P. Paes, J.C. Seidell, A. Bakker, Z. Voko, M.B. Breteler, A. de Boer Excess stroke among hypertensive men and women attributable to undertreatment of hypertension Stroke 30 1999 1312 1318
4. W.B. Kannel Blood pressure as a cardiovascular risk factor Prevention and treatment. JAMA 275 1996 1571 1576
5. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins for the Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
6. R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Friebach, K.A. Eberlien, J. Godwin, N. Qizilbash, J.O. Taylor, C.H. Hennekens Blood pressure, stroke, and coronary heart disease, part 2 short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 335 1990 827 838
7. J.A. Staessen, J.G. Wang, L. Thijs Cardiovascular prevention and blood pressure reduction a quantitative overview updated until 1 March 2003 J Hypertens 21 2003 1055 1076
8. Blood Pressure Lowering Treatment Trialists Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535
9. M. Pahor, B.M. Psaty, M.H. Alderman, W.B. Applegate, J.D. Williamson, C. Cavazzini, C.D. Furberg Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies a meta-analysis of randomised controlled trials Lancet 356 2000 1949 1954
10. R.B. Haynes, N. Wilczynski, K.A. McKibbon, C.J. Walker, J.C. Sinclair Developing optimal search strategies for detecting clinically sound studies in MEDLINE J Am Med Inform Assoc 1 1994 447 458
11. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff for the INVEST investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International VerapamilTrandolapril Study (INVEST) a randomized controlled trial JAMA 290 2003 2805 2819
12. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
13. H.R. Black, W.J. Elliott, G. Grandits, P. Grambsch, T. Lucente, W.B. White for the CONVINCE Research Group Principal results of the Controlled ONset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial JAMA 289 2003 2073 2082
14. A. Zanchetti, G. Bond, M. Hennig, A. Neiss, G. Mancia, C. Dal Palu, L. Hansson, B. Magnani, K.H. Rahn, J.L. Reid, J. Rodicio, M. Safar, L. Eckes, P. Rizzini on behalf of the ELSA investigators Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial Circulation 106 2002 r47 r52
15. M.J. Brown, C.R. Palmer, A. Castaigne, P.W. de Leeuw, G. Mancia, T. Rosenthal, M.L. Ruilope Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study Intervention as a Goal in Hypertensive Treatment (INSIGHT) Lancet 356 2000 366 372
16. N.O. Borhani, M. Mercuri, P.A. Borhani, V.M. Buckalew, M. Canossa-Terris, A.A. Carr, T. Kappagoda, M.V. Rocco, H.W. Schnaper, J.R. Sowers, M.G. Bond Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) A randomized controlled trial. JAMA 276 1996 785 791
17. National Intervention Cooperative Study in Elderly Hypertensives Study Group Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives Hypertension 34 1999 1129 1133
18. L. Hansson, T. Hedner, P. Lund-Johansen, S.E. Kjeldsen, L.H. Lindholm, J.O. Syvertsen, J. Lanke, U. de Faire, B. Dahlf, B.E. Karlberg for the NORDIL Study Group Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension the Nordic Diltiazem (NORDIL) study Lancet 356 2000 359 365
19. E. Malacco, G. Marcia, A. Rappelli, A. Menotti, M. Zuccaro, A. Coppini for the Shell Investigators Treatment of isolated systolic hypertension the SHELL study results Blood Press 12 2003 160 167
20. L. Hansson, L.H. Lindholm, T. Ekbom, B. Dahlof, J. Lanke, B. Schersten, P.-O. Wester, T. Hedner, U. de Faire for the STOP-Hypertension-2 study group Randomised trial of old and new antihypertensive drugs in elderly patients cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study Lancet 354 1999 1751 1756
21. A. Zanchetti, E. Agabiti Rosei, C. Dal Palu, G. Leonetti, B. Magnani, A. Pessina for the VHAS Study Group The Verapamil in Hypertension and Atherosclerosis Study (VHAS) results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness J Hypertens 16 1998 1667 1676
22. P. Tatti, M. Pahor, R.B. Byington, P. Di Mauro, R. Guarisco, G. Strollo for the FACET Study Group Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial (FACET) in patients with hypertension and NIDDM Diabetes Care 21 1998 597 603
23. R.O. Estacio, B.W. Jeffers, W.R. Hiatt, S.L. Biggerstaff, N. Gifford, R.W. Schrier The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulindependent diabetes and hypertension N Engl J Med 338 1998 645 652
24. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
25. Guidelines Committee 2003 European Society of HypertensionEuropean Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011 1059
26. U.T. Reugg, A. Wallnofer, S. Weir, C. Cauvin Receptor-operated calciumpermeable channels in vascular smooth muscle J Cardiovasc Pharmacol 14 Suppl 6 1989 S49 S58
27. R.W. Schrier, R.O. Estacio, A. Esler, P. Mehler Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes Kidney Int 61 2002 1086 1097
28. Y. Yui, T. Sumiyoshi, K. Kodama Long-term effects of nifedipine retard vs ACE inhibitors in hypertension with coronary heart disease final report of JMIC-B Circ J 66 Suppl 2002 357
29. C. Nicholson, G.T. Bruggencate, R. Steinberg, H. Stockle Calcium modulation in brain extracellular microenvironment demonstrated with ion selective micropipette Proc Natl Acad Sci USA 74 1977 1287 1290
30. B.K. Siesjo Cell damage in the brain a speculative synthesis J Cereb Blood Flow Metab 1 1981 155 185
31. T.N. Kristian, B.K. Siesjo Calcium in ischemic cell death Stroke 29 1998 705 718
32. F.C. Barone, P.G. Lysko, W.J. Price, G. Feuerstein, K.A. Al-Baracanji, C.D. Benham, D.C. Harrison, M.H. Harries, S.J. Bailey, A.J. Hunter SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice Stroke 26 1995 1683 1690
33. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, M.R. Babarskiene, S. Babeanu, A. Bossini, R. Fagard, B. Gil-Extremera, T. Laks, Z. Kobalava, C. Sarti, J. Tuomilehto, H. Vanhanen, J. Webster, Y. Yodfat, W.H. Birkenhager for the Systolic Hypertension in Europe Investigators The prevention of dementia with antihypertensive treatment new evidence from the Systolic Hypertension in Europe (Syst-Eur) study Arch Intern Med 162 2002 2046 2052
34. J. Horn, R.J. de Haan, M. Vermeulen, M. Limburg Very Early Nimodipine Use in Stroke (VENUS) a randomized, double-blind, placebo-controlled trial Stroke 32 2001 461 465
35. International Society of Hypertension Writing Group International Society of Hypertension (ISH) statement on blood pressure lowering and stroke prevention J Hypertens 21 2003 651 663
36. S.E. Straus, S.R. Majumdar, F.A. McAlister New evidence for stroke prevention clinical applications JAMA 288 2002 1396 1398